SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,941 | -50.9% | 85,689 | -1.1% | 0.00% | – |
| Q2 2023 | $415,039 | +73.0% | 86,647 | +104.8% | 0.00% | – |
| Q1 2023 | $239,858 | +7.7% | 42,303 | +6.4% | 0.00% | – |
| Q4 2022 | $222,673 | -11.6% | 39,763 | +1.5% | 0.00% | – |
| Q3 2022 | $252,000 | +152.0% | 39,174 | +33.6% | 0.00% | – |
| Q2 2022 | $100,000 | -51.7% | 29,324 | +1.0% | 0.00% | – |
| Q1 2022 | $207,000 | -14.5% | 29,045 | -0.2% | 0.00% | – |
| Q4 2021 | $242,000 | +19.8% | 29,110 | +0.1% | 0.00% | – |
| Q3 2021 | $202,000 | -45.6% | 29,074 | +87.0% | 0.00% | – |
| Q2 2021 | $371,000 | +26.2% | 15,549 | +9.3% | 0.00% | – |
| Q1 2021 | $294,000 | -18.6% | 14,230 | -3.4% | 0.00% | – |
| Q4 2020 | $361,000 | +98.4% | 14,732 | +129.2% | 0.00% | – |
| Q3 2020 | $182,000 | +435.3% | 6,427 | -11.2% | 0.00% | – |
| Q2 2020 | $34,000 | +70.0% | 7,238 | +31.4% | 0.00% | – |
| Q1 2020 | $20,000 | -23.1% | 5,508 | -27.3% | 0.00% | – |
| Q4 2019 | $26,000 | +8.3% | 7,580 | +24.3% | 0.00% | – |
| Q3 2019 | $24,000 | +140.0% | 6,097 | +80.3% | 0.00% | – |
| Q2 2019 | $10,000 | -56.5% | 3,381 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | +53.3% | 3,381 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -42.3% | 3,381 | 0.0% | 0.00% | – |
| Q3 2018 | $26,000 | -10.3% | 3,381 | 0.0% | 0.00% | – |
| Q2 2018 | $29,000 | +16.0% | 3,381 | 0.0% | 0.00% | – |
| Q1 2018 | $25,000 | -47.9% | 3,381 | -29.3% | 0.00% | – |
| Q4 2017 | $48,000 | -50.0% | 4,780 | -19.4% | 0.00% | – |
| Q3 2017 | $96,000 | +60.0% | 5,928 | +12.0% | 0.00% | – |
| Q2 2017 | $60,000 | +1.7% | 5,293 | 0.0% | 0.00% | – |
| Q1 2017 | $59,000 | +13.5% | 5,293 | 0.0% | 0.00% | – |
| Q4 2016 | $52,000 | +48.6% | 5,293 | +83.9% | 0.00% | – |
| Q3 2016 | $35,000 | -58.3% | 2,878 | 0.0% | 0.00% | – |
| Q2 2016 | $84,000 | +110.0% | 2,878 | +84.0% | 0.00% | – |
| Q1 2016 | $40,000 | -27.3% | 1,564 | 0.0% | 0.00% | – |
| Q4 2015 | $55,000 | – | 1,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |